Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy
RhumatEx
1 other identifier
interventional
8
1 country
1
Brief Summary
The main objective of this project is to study, in patients with rheumatoid arthritis, the effects of an intermittent type exercise associated with cryotherapy on the level of inflammation during its recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 2, 2016
CompletedFirst Posted
Study publicly available on registry
August 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFebruary 15, 2017
August 1, 2016
3.5 years
August 2, 2016
February 14, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
plasma concentration of C-reactive protein
48 hours after the end of the exercise
Study Arms (4)
constant exercise without cryotherapy
EXPERIMENTALconstant exercise without cryotherapy
constant exercise with cryotherapy
EXPERIMENTALconstant exercise with cryotherapy
intermittent exercise, no cryotherapy
EXPERIMENTALintermittent exercise without cryotherapy
intermittent exercise and cryotherapy
EXPERIMENTALintermittent exercise with cryotherapy
Interventions
Eligibility Criteria
You may qualify if:
- Men and women \>18 years old, \< 80 years old
- Signature of informed consent for participation
- Affiliation to a social security scheme or French beneficiary of such a regime.
- confirmed rheumatoid arthritis and monitoring by the rheumatology department of the University Hospital of Besancon.
- If there is a corticosteroid therapy, it must be stable for at least 1 month and less than or equal to 10 mg of prednisone equivalent per day
- Clinical and biological activity will be moderate (ie not in remission and not severe based on Disease Activity Score 28 joints - DAS 28 - to be between 2 and 6
- Patients could be treated with DMARDs (Disease-Modifying Drugs).
You may not qualify if:
- Patient under guardianship, curatorship, under judicial protection, major incapable
- Patients whose body mass index (BMI) greater than 30,
- Pathology incompatible with the completion of a cycle ergometer exercise (heart, vascular, respiratory, orthopedic ...)
- A patient with a DAS28 \> 6
- about the cold: Raynaud's syndrome, cold known allergy, sickle cell anemia, cryoglobulinemia, uncontrolled hypertension
- Patient unable to follow protocol because of cognitive, psychiatric or language difficulties.
- Inability to follow protocol for causes related to health problems (unrelated Rheumatoid Arthritis) or socio-professional.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Régional Universitaire
Besançon, Franche-Comté, 25030, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clement Pati, MD
CHRU Besancon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2016
First Posted
August 4, 2016
Study Start
June 1, 2013
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
February 15, 2017
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share